MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Total Assets 2011-2026 | IART
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.04 B | 3.78 B | 3.89 B | 3.78 B | 3.62 B | 3.3 B | 3.11 B | 3.21 B | 1.81 B | 1.77 B | 1.58 B | 1.2 B | 1.16 B | 1.14 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.04 B | 1.14 B | 2.67 B |
Quarterly Total Assets Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.67 B | 4.05 B | 4.07 B | 4.07 B | 4.08 B | 3.74 B | 3.78 B | 3.74 B | 3.89 B | 3.81 B | - | 3.67 B | 3.78 B | 3.77 B | 3.71 B | 3.74 B | 3.62 B | 3.62 B | 3.62 B | 3.62 B | 3.3 B | 3.3 B | 3.3 B | 3.3 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 3.21 B | 3.21 B | 3.21 B | 3.21 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 1.77 B | 1.77 B | 1.77 B | 1.77 B | 1.59 B | 1.59 B | 1.58 B | 1.58 B | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 1.16 B | 1.16 B | 1.16 B | 1.16 B | 1.14 B | 1.15 B | 1.15 B | 1.15 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.08 B | 1.14 B | 2.64 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
77.2 M | $ 3.22 | - | $ 121 M |  France |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 93.7 | -1.24 % | $ 12.7 B | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.12 | -1.85 % | $ 1.29 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
256 M | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 10.84 | - | $ 388 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 37.87 | -1.23 % | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 83.46 | -0.94 % | $ 48.8 B | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.34 | -2.62 % | $ 494 M | USA |
 |
NanoVibronix
NAOV
|
41.1 M | - | - | $ 1.08 M | USA |
 |
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.83 | 0.8 % | $ 34.7 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Natus Medical Incorporated
NTUS
|
564 M | - | 1.94 % | $ 1.05 B | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 12.32 | -0.24 % | $ 488 M |  Curacao |